1. UNAIDS. AIDS epidemic update: special report on HIV/AIDS: December 2006, www.unaids.org/en/HIV_data/epi2006/default.asp (last accessed on interent on October 2, 2007).
2. UNAIDS — Report on the global AIDS epidemic Geneva, December 2004, UNAIDS/WHO-AIDS epidemic update. UNAIDS 44 E-WHO/CDS/CSR/EDC/2000.9. Geneva, UNAIDS, December (2004). www.who.int/hiv/epi-update2005_en.pdf (Last accessed on internet on October 2, 2007).
3. Guay LA, Musoke P, Fleming T, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999, 354: 795–802.
4. Dabis F, Msellati P, Meda N, et al. 6-month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV in breastfed children in Côte d’Ivoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group Diminution de la transmission Mere-enfant. Lancet 1999, 353: 786–92.
5. Wiktor SZ, Ekpini E, Karon JM, et al. Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte d’Ivoire: a randomised trial. Lancet 1999, 353: 781–5.